Latest News

Iovance Biotherapeutics’ Lifileucel Produces Durable Responses in 5-Year Analysis of Advanced Melanoma Data
Iovance Biotherapeutics’ Lifileucel Produces Durable Responses in 5-Year Analysis of Advanced Melanoma Data

June 3rd 2025

The analysis included 153 patients with a median follow-up of 57.8 months.

Heather Landau, MD, the MSKCC Amyloidosis Program director and the NEXICART-2 principal study investigator
Immix Biopharma’s CAR-T NXC-201 Effects Deep Hematologic Responses in Light Chain Amyloidosis

June 3rd 2025

Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
The Potential to Apply Immunotherapy DOC1021 to a Broad Array of Tumor Types

June 2nd 2025

Jamie Jacobs, PhD, the program director of the center for psychiatric oncology & behavioral sciences at Mass General Cancer Center
Using a Digital App to Aid Caregivers for Patients Undergoing Hematopoietic Stem Cell Transplant

June 2nd 2025

Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Manali Kamdar, MD, on a Large Scale Analysis of CRS/ICANS in Patients Receiving Liso-Cel

June 2nd 2025

Video Interviews

Conference Coverage

View All
Iovance Biotherapeutics’ Lifileucel Produces Durable Responses in 5-Year Analysis of Advanced Melanoma Data
Iovance Biotherapeutics’ Lifileucel Produces Durable Responses in 5-Year Analysis of Advanced Melanoma Data

June 3rd 2025

Heather Landau, MD, the MSKCC Amyloidosis Program director and the NEXICART-2 principal study investigator
Immix Biopharma’s CAR-T NXC-201 Effects Deep Hematologic Responses in Light Chain Amyloidosis

June 3rd 2025

Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
The Potential to Apply Immunotherapy DOC1021 to a Broad Array of Tumor Types

June 2nd 2025

Jamie Jacobs, PhD, the program director of the center for psychiatric oncology & behavioral sciences at Mass General Cancer Center
Using a Digital App to Aid Caregivers for Patients Undergoing Hematopoietic Stem Cell Transplant

June 2nd 2025

All News

© 2025 MJH Life Sciences

All rights reserved.